Literature DB >> 29063355

Comment on "Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer" by Lan WG et al.

G Yavas1, C Yavas2, S Akyurek3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29063355     DOI： 10.1007/s12094-017-1775-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  5 in total

1.  HE4 expression in lung cancer, a meta-analysis.

Authors:  Hai Zhong; Yingying Qian; Surong Fang; Linfei Yang; Lingzhi Li; Wei Gu
Journal:  Clin Chim Acta       Date:  2017-05-09       Impact factor: 3.786

2.  Elevated human epididymis protein 4 concentrations in chronic kidney disease.

Authors:  Béla Nagy; Zoárd T Krasznai; Heidi Balla; Mária Csobán; Péter Antal-Szalmás; Zoltán Hernádi; János Kappelmayer
Journal:  Ann Clin Biochem       Date:  2012-06-11       Impact factor: 2.057

3.  Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer.

Authors:  W-G Lan; Y-Z Hao; D-H Xu; P Wang; Y-L Zhou; L-B Ma
Journal:  Clin Transl Oncol       Date:  2015-09-02       Impact factor: 3.405

4.  Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer.

Authors:  Béla Nagy; Harjit Pal Bhattoa; Zoltán Steiber; Mária Csobán; Mária Szilasi; Gábor Méhes; Mónika Müller; József Lázár; János Kappelmayer; Péter Antal-Szalmás
Journal:  Clin Chem Lab Med       Date:  2014-11       Impact factor: 3.694

5.  WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung.

Authors:  Lynne Bingle; Simon S Cross; Alec S High; William A Wallace; Doris Rassl; Guanglu Yuan; Ingegerd Hellstrom; Michael A Campos; Colin D Bingle
Journal:  Respir Res       Date:  2006-04-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.